Diagnostic and prognostic potential of gene microarrays in rheumatoid arthritis

Expert Review of Molecular Diagnostics

Volumn 5, Issue 5, 2005, Pages 655-659

  Jarvis, James N ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Gene expression arrays; Juvenile rheumatoid arthritis; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN M; METHOTREXATE; RHEUMATOID FACTOR;

CLINICAL PRACTICE; COST BENEFIT ANALYSIS; GENE EXPRESSION PROFILING; HEALTH EDUCATION; HUMAN; IMMUNOPATHOLOGY; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHYSICIANS; PROGNOSIS;

EID: 25144517714     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.5.5.655     Document Type: Review

References (25)

1. Jarvis JN. Mechanisms of pathogenesis and inflammation in the pediatric rheumatic diseases. Curr. Opin. Rheumatol. 10, 459-467 (1998).
2. Derk CT, Jimenez SA. Systemic sclerosis: current views of its pathogenesis. Autoimmun. Rev. 2, 181-191 (2003).
3. Sakkas LI, Platsoucas CD. Is systemic sclerosis an antigen-driven T-cell disease? Arthritis Rheum. 50, 1721-1733 (2004).
4. Newton JL, Harney SM, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. Genes Immun. 5, 151-157 (2004).
5. Jawaheer D, Gregersen PK. Rheumatoid arthritis. The genetic components. Rheum. Dis. Clin. N. Am. 28, 1-15 (2002).
6. Prahalad S, O'Brien E, Fraser AM et al. Familial aggregation of juvenile idiopathic arthritis. Arthritis Rheum. 50, 4022-4027 (2004).
7. Mauldin J, Cameron D, Jeanotte D, Solomon G, Jarvis JN. Rheumatic disease in children and adolescents in two Indian Health Service user populations. BMC Musculoskelet. Disord. 5, 30 (2004).
8. Van Roon JAG, Lafeber FPJG, Bijlsma JWJ. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum. 44, 3-12 (2001).
9. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 72, 50-53 (1996).
10. Carroll MC. The role of complement and complement receptors in the regulation of immunity. Ann. Rev. Immunol. 16, 545-568 (1998).
11. - T-cells in rheumatoid arthritis patients combine features of innate and adaptive immune systems. Arthritis Rheum. 44, 13-20 (2001).
12. Jarvis JN. Gene expression profiling in pediatric rheumatic disease: What have we learned? What can we learn? Curr. Prob. Rheum. (2005) (In Press).
13. Cuesta I, Kerr KL, Jarvis JN. Subspecialty referrals for pauciarticular juvenile rheumatoid arthritis. Arch. Pediatr. Adolescent Med. 154, 122-125 (2000).
14. McGhee JL, Burks F, Sheckels J, Jarvis JN. Identifying children with chronic arthritis based on chief complaints: absence of predictive value for musculoskeletal pain as an indicator of rheumatic disease in children. Pediatrics 110, 354-359 (2002).
15. Eichenfield AH, Athreya BH, Doughty RA, Cebul RD. Utility of rheumatoid factor in the diagnosis of juvenile rheumatoid arthritis. Pediatrics 78, 480-484 (1985).
16. McGhee JL, Kickingbird L, Jarvis JN. Clinical utility of ANA tests in children. BMC Pediatr. 4, 13 (2004).
17. Nell W, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43, 906-914 (2004).
18. Olsen NJ, Sokka T, Seehorn CL, Kraft B, Moore J, Aune TM. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann. Rheum. Dis. 63, 1387-1392 (2004).
19. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum. 48, 2132-2145 (2003).
20. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann. Rheum. Dis. 64, 196-201 (2005).
21. Yazici Y, Pincus T, Kautiainen H, Sokka T. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J. Rheumatol. 31, 1723-1726 (2004).
22. Callahan LF, Bloch DA, Pincus T. Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J. Clin. Epidemiol. 45, 127-138 (1992).
23. Pincus T, Callahan LF. Quantitative measures to assess, monitor and predict morbidity and mortality in rheumatoid arthritis. Baillieres Clin. Rheumatol. 6, 161-191 (1992).
24. Jarvis JN, Dozmorov I, Jiang K et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res. Ther. R15-R32 (2004)
25. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Related articles, role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201(9), 1479-1486 (2005).